Johnston, Iowa, USA and Dublin, Ireland
June 27, 2017
DuPont Pioneer (DuPont) and ERS Genomics (ERS) announced a technology license agreement whereby DuPont gains exclusive rights to the ERS patent portfolio covering CRISPR-Cas genome editing technology for all agricultural uses and applications in plants. ERS was formed to commercialize the foundational intellectual property (IP) of the CRISPR-Cas technology from co-inventor and co-owner Emmanuelle Charpentier, Ph.D.
“We see CRISPR-Cas technology as an advancement in plant breeding which can enable a new era in crop improvement. This licensing agreement with ERS is a piece of DuPont Pioneer’s strategy to position our business as a leader in the application of CRISPR-Cas in agriculture,” said Neal Gutterson, vice president, Research & Development at DuPont Pioneer. “Our intention is to collaborate with public and private entities globally, to apply CRISPR-Cas to a wide set of crops and maximize the value of this important technology for the greater good.”
"This technology has had a tremendous impact on biological research and holds promise across a range of important applications," said Eric Rhodes, CEO of ERS Genomics. "We are proud to have DuPont Pioneer, a leading innovator in agriculture, as one of our key strategic licensees as we continue to make the technology broadly available for all other available applications through licensing."
The licensing agreement with ERS complements DuPont’s previously announced CRISPR-Cas licensing and collaboration agreements with Caribou Biosciences and Vilnius University. Financial terms of the agreement were not disclosed.
The DuPont patent estate comprises more than 60 patents and patent applications related to the use of CRISPR for bacteria identification and immunization. It also comprises patent applications related to CRISPR-Cas gene editing technology.
Pioneer is applying CRISPR-Cas as an advanced plant breeding tool to develop seed products for greater environmental resiliency, productivity and sustainability. Pioneer has defined CRISPR-Cas guiding principles, which include helping enable others wanting to develop agricultural products using CRISPR-Cas by providing access to its IP, technology capabilities, infrastructure and scientific expertise.
ERS Genomics was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property held by Emmanuelle Charpentier, Ph.D. Non-exclusive licenses are available for research and sale of products and services across multiple fields including: research tools, kits, reagents; discovery of novel targets for therapeutic intervention; cell lines for discovery and screening of novel drug candidates; GMP production of healthcare products; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology. For additional information please visit www.ersgenomics.com.
DuPont Pioneer is the world's leading developer and supplier of advanced plant genetics, providing high-quality seeds to farmers in more than 90 countries. Pioneer provides agronomic support and services to help increase farmer productivity and profitability and strives to develop sustainable agricultural systems for people everywhere. Science with Service Delivering Success®
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials and services since 1802. The company believes that by collaborating with customers, governments, NGOs and thought leaders, we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and
Topics
Species
